Google TrendPANTHERS VS BLUE JACKETS (200+) — Gameday 7: Florida Panthers at Columbus Blue Jackets
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Radiotherapy Plus Chemo B" (30 stories)

Top Headline Story

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial
Lead StoryNaturetech
Dec 23, 2025

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9XTVdVbGl6cFVVbWNvaFIwbnJWd2NYemVkSUV3SGI0NFcweXplS3paSDFwV3YwUXhOWW5KTG5BaFZBN1pMc3VQaWt1TVN5OFZFQkZnZ0xnWmZyWXVjVFlr?oc=5" target="_blank">Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
200+23m ago

panthers vs blue jackets

Gameday 7: Florida Panthers at Columbus Blue Jackets

5000+33m ago

posiciones de atlético de madrid contra manchester united

La quinta para el 6

2000+33m ago

devils vs red wings

Roster Changes for Devils vs. Red Wings | PREVIEW | New Jersey Devils

5000+33m ago

lioness season 3

Thank Zoe Saldaña for ‘Lioness’ Season 3’s Perfect Cliff-Hanger

Search Results for "Radiotherapy Plus Chemo B"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Radiotherapy Plus Chemo Benefits Certain Patients With DLBCL
AJMCtech

Radiotherapy Plus Chemo Benefits Certain Patients With DLBCL

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxObFR3VWNlU2tROU8wMWJ1c3pka2l3ck5pMVppTDdWbVNuRlVPZjR2aTJocHdlcjAxOEo1dUtwcl9zU3RkSnBHNU1nSEhVS2xWbUN2WHo2VGdpS1NOUVRxb1hBb1RDeE1PM256MjhQSVo1dEY3NjVITnVrWmhlelhwZFlyZDNaM1RPTWNCTG5JZw?oc=5" target="_blank">Radiotherapy Plus Chemo Benefits Certain Patients With DLBCL</a>  <font color="#6f6f6f">AJMC</font>

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
NEJMgeneral

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE83RHZ1dmRxNXZvRFVLRDl1N056c2U2QThycXQ3N0lNXzZYdFJlVEN6YUxjQWxVN002djlFWjd3R1podVZXTmh4ejcwaFRkUTBMdjhqTEpydlpYcVM3cjN3?oc=5" target="_blank">Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma</a>  <font color="#6f6f6f">NEJM</font>

Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis
Haematologicageneral

Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis

<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE9ZbmVXNTYwVXVPM3E0SDI4ZV9yZzlQT1hmM1ZIVERaSkRMRFFSM3luR2JFZDR4bWlvbDhQMC1aRFNjNHotQnFEdnhBZU0yQWZ0ZEF5V05R?oc=5" target="_blank">Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis</a>  <font color="#6f6f6f">Haematologica</font>

The Evolving Role of Radiation Therapy in DLBCL: From Early-Stage to Refractory Disease
CancerNetworkgeneral

The Evolving Role of Radiation Therapy in DLBCL: From Early-Stage to Refractory Disease

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPQzY0STZHc3c1LWM4bkQzeG50Vl81UUpMWml4NnptTS13djFRM3lNei12dmpIU0ZTZ19feVRlS0o3ZjVQdks2ZDlQOUh0Z3AzY0xEQmZTZ21mTEJWVnhLQXdNT0dRUWo5aUFyQk9BZ3NPQThaYzg2ZU4xS29rYzlHWDZuYTJPVjhWYV92NllWT3JzdkQ1eEItZjZpbjRQVXJ4eU9sUjVDQ2VqNjVRYk45RjRmQktuVGJXamxKam1n?oc=5" target="_blank">The Evolving Role of Radiation Therapy in DLBCL: From Early-Stage to Refractory Disease</a>  <font color="#6f6f6f">CancerNetwork</font>

Chemoimmunotherapy Responses May Allow for Omission of Radiotherapy in Lymphoma
Cure Todayworld

Chemoimmunotherapy Responses May Allow for Omission of Radiotherapy in Lymphoma

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQZ083NW9tY2RoRTNhZ0dpVWJRRzdLUXdieXJkcmxTUTl0QS1hN2hVbGFpWXc0bWMzSFVSUGE2QVRpejc0aDJrT01OY29nQ05OOHdlTnd0VWN2NzZDejVMWEtlTEFCN3hpNHFuWW9CQlU2eU50Z21iVWVHbTRxVUxQN2RVeWFxWUI5cE9BalA2YzFSd1pHQ0N5a0trTFJoZXVRZkpkMGtmX0pxaWhQcWJN?oc=5" target="_blank">Chemoimmunotherapy Responses May Allow for Omission of Radiotherapy in Lymphoma</a>  <font color="#6f6f6f">Cure Today</font>

High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project
Naturegeneral

High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5fclVsZGd0S1hMMGdoZU1QX3V0N1FPWTNvLVQ0Mzh5Sm1JRGdqdlg5aHZldGFlZzQwSnVHbFNWUTFCcEc4TkRHd1dadDNEb1JlLTlRbkVVU0lRRTduUFpn?oc=5" target="_blank">High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project</a>  <font color="#6f6f6f">Nature</font>

Preoperative Treatment of Locally Advanced Rectal Cancer
NEJMgeneral

Preoperative Treatment of Locally Advanced Rectal Cancer

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5VbDYwNzhyaEdJc1V4TV9SOTJQMFA0VjBlV0VMOVRWUE0yVms0YU9mUGVVWVRhMmVRbEJUSkoydXlxSmp0a0p0YUJPaVNfVHlrZHhjOExDUUNMZk5ROFd1LQ?oc=5" target="_blank">Preoperative Treatment of Locally Advanced Rectal Cancer</a>  <font color="#6f6f6f">NEJM</font>

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
NEJMgeneral

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5WTDBfb1dHenZLUEJlaVBIQzdyM1FBV0VSUHJHeWN5SVp0S29fNW5xQ3d5ZjdkUXliMzY5aHJZWWc0RTJ3UDkxXzRBdVRvNXkyTW12bHFUS29iZ2E4Q3RsYw?oc=5" target="_blank">Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer</a>  <font color="#6f6f6f">NEJM</font>

Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial
Naturetech

Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5POW02M21CZ1REOWxMd2Q5a3FTWUYtUzBLS1pUeTZHR2k5M0hEWm5vQmlhMXdCaWZNR2VZZmhBaUtpMFhWendtc2xJUVlueldYd1RXcE9xR293bGhJaTRv?oc=5" target="_blank">Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial</a>  <font color="#6f6f6f">Nature</font>

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
NEJMgeneral

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1RbVV3UldoWWpkRmNuVUJwakJGaVJMOHlUMnR4WlBBbUgxQi1wb0t1ejI2R3l3XzJuejFpaktodjVNaktvY0Y5cHA0R2ZUdFo5R1MxbWxyUHl6T1dVRzB6VA?oc=5" target="_blank">Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma</a>  <font color="#6f6f6f">NEJM</font>

Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer
Naturegeneral

Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9pWEFKdnR3djBiVFFfdk1GaU9KZ29SOGk1aWNEV2Naa3RHaTZCSTNSWHZHWVkyUkh6aDRzWEp2RHhGbTFoWWE0eTduVk9tVnRyQVJOZmhXbE5GOWI3cTZz?oc=5" target="_blank">Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer</a>  <font color="#6f6f6f">Nature</font>

Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
NEJMgeneral

Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFB6YThxd0N6UUhTOE96MzJaWDRQTEUzbTFVRWxJbFJBZ1pOaGwxWE9reTVaSzFQMWtuVnR5LWlpbGZYTW5QMVpvWk5uRWZ4bzdKTWVHSVVPM3VqRUtCWGdZaw?oc=5" target="_blank">Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer</a>  <font color="#6f6f6f">NEJM</font>

Radiotherapy in younger patients with advanced aggressive B-cell lymphoma—long-term results from the phase 3 R-MegaCHOEP trial | Leukemia
Natureworld

Radiotherapy in younger patients with advanced aggressive B-cell lymphoma—long-term results from the phase 3 R-MegaCHOEP trial | Leukemia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBjM2lNYmI3U1hkbTA5ejh5MEJyTGxQQVgxVnM4NzZNMGhPblY3NXpmNEZXR0VmMXVZejdJNFlUQV9UdVYwVzNwWGVSRkhEMWZxTnFlZEhuWF90ZEtHbHNR?oc=5" target="_blank">Radiotherapy in younger patients with advanced aggressive B-cell lymphoma—long-term results from the phase 3 R-MegaCHOEP trial | Leukemia</a>  <font color="#6f6f6f">Nature</font>

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
NEJMgeneral

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5LOER6QjRpM3RsUmZMdWJOQkJCaGl0YjhJenNVUmFKaFBYekxTaGRRTURZWUJLTFFwUTY2N0NSdm1WWnUtTnVESG52Q19WMmJtcmtrV1R4MTNHX2hEcWpZ?oc=5" target="_blank">Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck</a>  <font color="#6f6f6f">NEJM</font>

On-chip combined radiotherapy and chemotherapy testing on soft-tissue sarcoma spheroids to study cell death using flow cytometry and clonogenic assay
Naturetech

On-chip combined radiotherapy and chemotherapy testing on soft-tissue sarcoma spheroids to study cell death using flow cytometry and clonogenic assay

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1VdncyNTRja1pYUEx1U2ZfZUozYjdrOWtleEluaDMtdGNNQ18xSFV6Q1gyM2MxekFJUDg0dlZwaVdETkdzRXZ4b2JBTmIxMWxCem9lRklIQnctd1FSNXVB?oc=5" target="_blank">On-chip combined radiotherapy and chemotherapy testing on soft-tissue sarcoma spheroids to study cell death using flow cytometry and clonogenic assay</a>  <font color="#6f6f6f">Nature</font>

Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma
NEJMgeneral

Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE1wSnNhVXQ5VjhVVWp3RmRicmJwQnl3akV1Y0R3enNaZnl1b2FkdXhabDlEemFFQ2loTEJIN0ZBc0FURkdPSTdaWWtKOVRvMHo1NFdEaDU1OFJPZnNzSENyMFFjd294WDZS?oc=5" target="_blank">Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma</a>  <font color="#6f6f6f">NEJM</font>

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
NEJMgeneral

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5EQWhqMTcydGpSbFNMS2hLWktUUWYxeGRaZXYtYkUtOV90cmVFUV8tTG1LRjVXTEJfOU1NUFJueVl5eTNCRkpGNjZGaGM5cVNscW5jRjc2M3E1ZnlOQ0Fj?oc=5" target="_blank">Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck</a>  <font color="#6f6f6f">NEJM</font>

Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
NEJMgeneral

Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE93eTllVDItNXc4TldRbWVhVVdNVjJhaFJ1WUtNN3E2d2tSUGJsNGFQSmc1eHBieFFYQ0c3OVZXazFmZUNzMF9SSml1OG5UX1I3SXRuNXdwUzdpcTYtNTZR?oc=5" target="_blank">Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer</a>  <font color="#6f6f6f">NEJM</font>

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
NEJMgeneral

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1MZW4xRjFITDZJVzc3TjU0ZnFBcjdNLXpsaHBMaDJjaU9XZTREMnN0UV9qZXdCUGFMQjAwekh3cWJaX0c2ZmtLSTB0X3V2aEJQaDUzUHhJZjJPbGcyTjRDWQ?oc=5" target="_blank">Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma</a>  <font color="#6f6f6f">NEJM</font>

Comparison Long-term Outcome of Definitive Radiotherapy plus Different Chemotherapy Schedules in Patients with Advanced Nasopharyngeal Carcinoma
Naturegeneral

Comparison Long-term Outcome of Definitive Radiotherapy plus Different Chemotherapy Schedules in Patients with Advanced Nasopharyngeal Carcinoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1raEU3NkF3YUV2QnZEVE14cWRGb1RSRmhQd2pKU2Y0VERZQktJZ3VLTHlSaFVaUFhXeGdScmY3d09uZHRqY2RxTkF1ZkhxeHI0SEFFVURaX2V3c2pSX2ow?oc=5" target="_blank">Comparison Long-term Outcome of Definitive Radiotherapy plus Different Chemotherapy Schedules in Patients with Advanced Nasopharyngeal Carcinoma</a>  <font color="#6f6f6f">Nature</font>

Effect of whole-brain radiotherapy with platinum-based chemotherapy in non-small cell lung cancer patients with multiple metastases including brain metastases
Naturetech

Effect of whole-brain radiotherapy with platinum-based chemotherapy in non-small cell lung cancer patients with multiple metastases including brain metastases

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBKbFQtcHh0MWtDMUgwSlVXNFlWTFc3dFFMaldnZ3pnMXd4WTBXZkFpYlZWWEtxbG9seDEzd3BxVXpDTExDQkh1TnFGNDVqdXFHUFRDdS12Y21ZT3dPVVlV?oc=5" target="_blank">Effect of whole-brain radiotherapy with platinum-based chemotherapy in non-small cell lung cancer patients with multiple metastases including brain metastases</a>  <font color="#6f6f6f">Nature</font>

Radiation Therapy in Diffuse Large B-Cell Lymphoma: A Little Boost Gets You Over the Finish Line
CancerNetworkgeneral

Radiation Therapy in Diffuse Large B-Cell Lymphoma: A Little Boost Gets You Over the Finish Line

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxPVlR0aF94UlJRc0QzcTctbm5sdjhOSmg5RWMyalJsQ2xHTDJpVzlRMG8wdU1DSDZFWFhrSmJzcnk1S0dhM3BPNWJyR08xaEhhcDI4dXZFOXRWRjVWdW91MzRBa2FfNC14RF84aG5OVU5xWmRzdl9vRVdnVkpxYlNDczNfcEVfay1HM1dtVFpBY0NTSjZYY3NYTWM0N28wTkoyaDlWUlVGRUxIOGt4R0JVRmVPOE1tUHBoWUF3OXp0bnA3RHllYXlIV2pB?oc=5" target="_blank">Radiation Therapy in Diffuse Large B-Cell Lymphoma: A Little Boost Gets You Over the Finish Line</a>  <font color="#6f6f6f">CancerNetwork</font>

Radiotherapy May Not Be Necessary After Chemotherapy in Some Patients With PMBCL
Hematology Advisorgeneral

Radiotherapy May Not Be Necessary After Chemotherapy in Some Patients With PMBCL

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRVg3WDVkb2JabEVKdHlOTWFZVVJFTXRoUEVabG10c1NXMExONkNIUEdtdVlxZU1yNEtreUNBMXRqU0FlbFYyRTZDakJXcUxxQl8yY2pfMk4zbU9mNWJfUnNlV01PY09ya3hMLUF6TEtid0pRdjF3RkFDVVV3SlFqOGR1ZlpxZnJNWUVvQXlTZ0xwWHpkSnVLWjh1akI4bERGV1Z6QzZUSzBscU0?oc=5" target="_blank">Radiotherapy May Not Be Necessary After Chemotherapy in Some Patients With PMBCL</a>  <font color="#6f6f6f">Hematology Advisor</font>

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
The Lancetworld

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxNUGllRmt5Yk5jVXZyOGVQNTVTbFdFLWtMWGlmS3kyLVpNa0FEQV9jdDc1bTI4RTVVaFNPZTVTLWFTMFRQZERzT0RSNjIwc0tlRkppbzVXZlNwdGNfaUt3TTZtOU9vLVNPdENhM2g2VWZJYkJXMi0xejM3T2x5T2hVSFRJMHVMUQ?oc=5" target="_blank">Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial</a>  <font color="#6f6f6f">The Lancet</font>

Pembrolizumab Plus Concurrent Chemoradiation Continues to Induce Durable Responses in Previously Untreated Stage III NSCLC
CancerNetworkworld

Pembrolizumab Plus Concurrent Chemoradiation Continues to Induce Durable Responses in Previously Untreated Stage III NSCLC

<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxON2p1VnExX2ZJUm53SWdjR18xdVdfNlptS01yNWp3WGJpQUoxVVBVaHhxYlRNMld6UnVnMjF3ZV9ob2cxZ2g1TGxla3ZXaWFYcUtJd3JfOFNTTWhweDZ0VlA2Z1ByYU5iOUxRWFhQNlM4VFFhblcxN2xZaDNWRk1mQ19HUS10UmZoWXJYNjV1QXJsYkZYZk9CVDhxcHRFSTIxSnVuQ194YThJQS1hTno5aVhGajkxR3ZTQ2JoN21NVjFLdWJHUHhPVjBLUmdCb0hzU1NPeVZheGpSS3N5ZWZOcERxNlZHSDZYU09j?oc=5" target="_blank">Pembrolizumab Plus Concurrent Chemoradiation Continues to Induce Durable Responses in Previously Untreated Stage III NSCLC</a>  <font color="#6f6f6f">CancerNetwork</font>

Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
NEJMgeneral

Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE9lN3dLS1lNVWdGbExuNXRGWFBmWDVsR2ljNVA1T2duRkFjdWk3X1FYeS1LNXF6cUNEMEJxdzVkbmRTZWtxOXdCOFc0TUpKbkxLMndUUWJqaEpLR1F3WVdqWWpwYkZ4YnRH?oc=5" target="_blank">Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer</a>  <font color="#6f6f6f">NEJM</font>

Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
NEJMworld

Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE8yWUh4c04xeUQ4N0FqRjNqZ082dC0tWS1QV3hxU0l2VlBYamV5aEg1T2g2REhPdDBCMUVDREtKQVVwckotNXQ0akNBeVZ1bnpEN0VIekw0NzVvNGVTd0dz?oc=5" target="_blank">Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction</a>  <font color="#6f6f6f">NEJM</font>

Adding Durvalumab to Neoadjuvant Regimen Improves Pathologic Complete Response Rate in High-Risk Breast Cancer
The ASCO Postgeneral

Adding Durvalumab to Neoadjuvant Regimen Improves Pathologic Complete Response Rate in High-Risk Breast Cancer

<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxOVEV4WF9NMjZYUzFxbGo1RDRuSElkZFNpZUhzeFRFVzFzS2E5Uk5VQnNQZnBsTDJtSm93LW1MNjlqa0dxZ04xVnl1T2JFZl9lc3VlaENsOWRsc0VnZl9EUU1ZT0FEbEZ6QmVNTThWekc4MG5rdVc0NlRZR0VfOTlYeEhDS0ZkMXl0Ty1LajRmQlJvdW5QLU5fejVVcEhOZDZwVkFaWHlrdXhZNnp2dkNPd21aRDZJbFl0S3dEZFlmZHdZbUp2TWdDNFpKdE5NVXhxS1RidEdRNEZPZkJDckRrRmpVRXlFM3hiaThnbQ?oc=5" target="_blank">Adding Durvalumab to Neoadjuvant Regimen Improves Pathologic Complete Response Rate in High-Risk Breast Cancer</a>  <font color="#6f6f6f">The ASCO Post</font>

Radiotherapy Plus Chemoimmunotherapy Improves Frontline ES-SCLC Prognosis
CancerNetworkworld

Radiotherapy Plus Chemoimmunotherapy Improves Frontline ES-SCLC Prognosis

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQLWVGcHE1NEkwREdJSE50WnFPMTRleVMwV1BIVkR1eHFJSkFqcGJqUnlRWTlWalRsd3g0blRvT3cydUUxSE1pZWtvSll3SXR4LUZMU09oOGE0S2tWYkhTelRBSURPU3BZWlpOelcyNm5MaXZnMTlzRVAxaUVKalJvR3NSdU5MbUNfRHBmQXpoc05nWE15UEFoTVMwNS1qbEhZVmxQMmtxeTlqRzFx?oc=5" target="_blank">Radiotherapy Plus Chemoimmunotherapy Improves Frontline ES-SCLC Prognosis</a>  <font color="#6f6f6f">CancerNetwork</font>

"Radiotherapy Plus Chemo B" — Live Google News Trends & Headlines